Clinical Trial Update: Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for an intravesical antifibrinolytic aimed at patients with hematuria and clot retention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Hematuria
• Prostate Cancer
• Urinary Retention
• Urologic Diseases

Snippet

Sponsor: Fraser Health | Conditions: Urologic Diseases, Prostate Cancer | Phase 1, Phase 2 | Status: COMPLETED